ask="7.65"
ask_size="800"
average_daily_volume="240461"
bid="7.35"
bid_size="300"
book_value="3.42"
change="+0.23"
change_from_200_day_moving_average="-0.94"
change_from_50_day_moving_average="-0.18"
change_from_52_week_high="-5.17"
change_From_52_week_low="1.74"
change_in_percent="+3.24%"
close="7.33"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.07"
ebitda="-1.40M"
eps_estimate_current_year="-2.92"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-2.64"
ex_dividend_date="N/A"
float_shares="5020000"
high="7.39"
high_52_weeks="12.50"
last_trade_date="1/18/2017"
last_trade_price="7.33"
last_trade_size="100"
last_trade_time="4:00pm"
low="7.00"
low_52_weeks="5.59"
market_capitalization="89.15M"
moving_average_200_day="8.27"
moving_average_50_day="7.51"
name="Recro Pharma
Inc."
notes="N/A"
one_year_target_price="20.50"
open="7.07"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-11.32%"
percent_change_from_50_day_moving_average="-2.35%"
percent_change_from_52_week_high="-41.36%"
percent_change_from_52_week_low="+31.13%"
previous_close="7.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.07"
price_per_sales="1.26"
revenue="68.73M"
shares_outstanding="12163000"
short_ratio="2.08"
stock_exchange="NCM"
symbol="REPH"
volume="63494"
weeks_range_52="5.59 - 12.50"
